메뉴 건너뛰기




Volumn 27, Issue 18, 2009, Pages 3064-

Cause-specific colostomy rates after chemoradiotherapy for anal carcinoma: Cancer-related versus treatment-related colostomy

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN; ANTINEOPLASTIC AGENT;

EID: 67649977050     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.8890     Document Type: Letter
Times cited : (6)

References (3)
  • 1
    • 61449252531 scopus 로고    scopus 로고
    • US Intergroup Anal Carcinoma Trial: Tumor diameter predicts for colostomy
    • Ajani JA, Winter KA, Gunderson LL, et al: US Intergroup Anal Carcinoma Trial: Tumor diameter predicts for colostomy. J Clin Oncol 27:1116-1121, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 1116-1121
    • Ajani, J.A.1    Winter, K.A.2    Gunderson, L.L.3
  • 2
    • 42449128805 scopus 로고    scopus 로고
    • Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. JAMA 299:1914-1921, 2008
    • Ajani JA, Winter KA, Gunderson LL, et al: Fluorouracil, mitomycin, and radiotherapy vs. fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal. JAMA 299:1914-1921, 2008
  • 3
    • 0035022691 scopus 로고    scopus 로고
    • Intracavitary afterloading boost in anal carcinoma: Results, function, and quality of life
    • Vordermark D, Flentje M, Sailer M, et al: Intracavitary afterloading boost in anal carcinoma: Results, function, and quality of life. Strahlenther Onkol 177:252-258, 2001
    • (2001) Strahlenther Onkol , vol.177 , pp. 252-258
    • Vordermark, D.1    Flentje, M.2    Sailer, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.